| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/08/2012 | EP2414043A1 Bmp-alk3 antagonists and uses for promoting bone growth |
| 02/08/2012 | EP2413969A2 Fusion proteins comprising canine fc portions |
| 02/08/2012 | EP2413968A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses |
| 02/08/2012 | EP2413967A1 Treatment of insulin-resistant disorders |
| 02/08/2012 | EP2413966A1 Combination therapy of an afucosylated antibody and one or more of the cytokines selected from human gm-csf, human m-csf and/or human il-3 |
| 02/08/2012 | EP2413965A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan |
| 02/08/2012 | EP2413964A2 Vaccine compositions and methods of use thereof |
| 02/08/2012 | EP2413963A1 Methods of use for hsv-1 and hsv-2 vaccines |
| 02/08/2012 | EP2413962A1 Influenza virus vaccines and uses thereof |
| 02/08/2012 | EP2413961A1 Method for prophylaxis of influenza using vaccine for intranasal administration |
| 02/08/2012 | EP2413960A1 Diagnostic test for virus |
| 02/08/2012 | EP2413959A1 Compositions comprising chlamydia antigens |
| 02/08/2012 | EP2413958A1 Cytokines and neuroantigens for treatment of immune disorders |
| 02/08/2012 | EP2413957A2 Pharmaceutical composition |
| 02/08/2012 | EP2413956A1 Identification, optimization and use of cryptic hla-a24 epitopes for immunotherapy |
| 02/08/2012 | EP2413950A2 Antigenic peptide of hsv-2 and methods for using same |
| 02/08/2012 | EP2413905A2 Formulation |
| 02/08/2012 | EP2102235B1 Treatment of cachexia |
| 02/08/2012 | EP2045328B1 Peptide and nucleotide sequences of anisakis spp. and uses thereof |
| 02/08/2012 | EP2010562B1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same |
| 02/08/2012 | EP1945251B1 Prime boost vaccine for the protection of equines against equine influenza |
| 02/08/2012 | EP1711531B1 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof |
| 02/08/2012 | EP1635867B1 Composition comprising iscom particles and live micro-organisms |
| 02/08/2012 | EP1608393B1 Ebola peptides and immunogenic compositions containing same |
| 02/08/2012 | EP1567117B1 Prevention and treatment of microbe-mediated epithelial disorders |
| 02/08/2012 | EP1543165B1 Assays for assembly of ebola virus nucleocapsids |
| 02/08/2012 | EP1537203B1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 02/08/2012 | EP1267924B1 Immunotherapeutic methods and compositions |
| 02/08/2012 | CN1921884B 重组核酸分子,表达盒和细菌,及其使用方法 Recombinant nucleic acid molecule, expression cassette, and bacteria, and methods of use |
| 02/08/2012 | CN1758900B 药物组合物 The pharmaceutical composition of |
| 02/08/2012 | CN102348981A A PKN3/RhoC macromolecular complex and methods of use therefor |
| 02/08/2012 | CN102348796A Novel cancer antigen eEF2 |
| 02/08/2012 | CN102348466A West nile virus vaccine |
| 02/08/2012 | CN102344916A Rheumatoid arthritis specific antigen |
| 02/08/2012 | CN102344914A Construction and application of recombinant MDV (Marek's Disease Virus) strain for expressing REV env (Reticuloendotheliosis Viruses envelope) |
| 02/08/2012 | CN102344913A Construction of rabies virus G protein expression recombinant canine distemper virus CDV/R-20/8 vaccine strain |
| 02/08/2012 | CN102344912A Porcine pseudorabies virus strain and porcine pseudorabies inactivated vaccine prepared by using same |
| 02/08/2012 | CN102344892A Chinese isolate of Leachiii mycoplasma, isolation medium and purpose thereof |
| 02/08/2012 | CN102344491A Interferon alpha antibodies and their uses |
| 02/08/2012 | CN102343103A Screening and verifying of human papilloma virus (HPV) 16 tripeptide vaccine and construction of tumor animal model for continually expressing HPV16 E5, E6 and E7 |
| 02/08/2012 | CN102343090A Pharmaceutical composition for treating rheumatoid arthritis |
| 02/08/2012 | CN102343089A A medical composition for treating breast cancer |
| 02/08/2012 | CN102343088A Canine infectious tracheobronchitis bivalent live vaccine and preparation method thereof |
| 02/08/2012 | CN102343087A Preparation of diploid cell attenuated live vaccine from measles long-47 strain and preparation process thereof |
| 02/08/2012 | CN102343086A Drug and tumor whole-cell vaccine for treating or preventing tumor, and preparation methods and applications of drug and whole-cell vaccine |
| 02/08/2012 | CN101914499B Anti-waterfowl parvovirus VP3 protein monoclonal antibody |
| 02/08/2012 | CN101875696B 一种抗体及其制备方法与应用 An antibody preparation method and application |
| 02/08/2012 | CN101838658B O type foot-and-mouth disease virus variant as well as coding gene and application thereof |
| 02/08/2012 | CN101818163B 表达亚洲1型口蹄疫病毒vlp的重组腺病毒及其应用 FMD virus type Asia 1 expression vlp adenovirus and its application |
| 02/08/2012 | CN101693109B 预防奶牛金黄色葡萄球菌乳房炎的酵母葡聚糖增效灭活苗 Prevention of Staphylococcus aureus mastitis in cows yeast glucan synergistic inactivated vaccine |
| 02/08/2012 | CN101691406B 一种新型融合蛋白ssi、其用途及专用基因 A novel fusion protein ssi, its purpose and special genes |
| 02/08/2012 | CN101612395B 一种培养敏感细胞生产蓝耳病疫苗的方法 A production of PRRS vaccines sensitive cell culture method |
| 02/08/2012 | CN101519440B 一种交叉保护性疫苗抗原及其制备方法和应用 One kind of cross-protective vaccine antigen and its preparation method and application |
| 02/08/2012 | CN101474403B 灭活疫苗的油佐剂 Oil adjuvant inactivated vaccine |
| 02/08/2012 | CN101455839B 迟缓爱德华菌抗独特型抗体基因工程疫苗及其制备方法 Edward slow bacterial anti-idiotype antibody genetically engineered vaccine and its preparation method |
| 02/08/2012 | CN101245100B 具有免疫保护功能的鼠疫菌蛋白与编码基因及其应用 Yersinia pestis protein-coding genes have immune protection function and its application |
| 02/08/2012 | CN101217978B 通过给予神经生长因子拮抗剂及其组合物来治疗骨关节炎疼痛的方法 By administering an antagonist of nerve growth factor and combinations thereof to treat osteoarthritis pain |
| 02/07/2012 | US8110662 Culture product; hybridization; antibody that binds to purified polypeptide |
| 02/07/2012 | US8110661 Anti-IP-10 antibodies and methods of use thereof |
| 02/07/2012 | US8110657 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/07/2012 | US8110653 Collections of repeat proteins comprising repeat modules |
| 02/07/2012 | US8110550 HDAC inhibitors and hormone targeted drugs for the treatment of cancer |
| 02/07/2012 | US8110546 VEGF antagonist formulations |
| 02/07/2012 | US8110543 Anti-invasive and anti-angiogenic compositions |
| 02/07/2012 | US8110541 Antigen delivery vectors and constructs |
| 02/07/2012 | US8110540 Antigen delivery vectors and constructs |
| 02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
| 02/07/2012 | US8110370 IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer |
| 02/07/2012 | US8110367 Methods for diagnosing renal disorders |
| 02/07/2012 | US8110354 Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 02/07/2012 | US8110224 Matrix containing biodegradable polymer, water soluble polymer and drugs; mixture containing water insoluble surfactant such as lecithin or phosphatide |
| 02/07/2012 | US8110204 Method of treating human-immunodeficiency virus (HIV) disease infection |
| 02/07/2012 | US8110202 Synthetic vaccine for tick control |
| 02/07/2012 | US8110201 Fusion proteins of mycobacterium tuberculosis |
| 02/07/2012 | US8110200 Fusion proteins of Mycobacterium tuberculosis |
| 02/07/2012 | US8110199 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 02/07/2012 | US8110198 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 02/07/2012 | US8110197 Heat resistant toxin polypeptide for use as adjuvant in developing vaccine for prevention and treatment of gastrointestinal disorders in humans and domestic animals |
| 02/07/2012 | US8110196 Methods and compositions for polytopic vaccination |
| 02/07/2012 | US8110195 Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody |
| 02/07/2012 | US8110194 CTLA-4 antibody dosage escalation regimens |
| 02/07/2012 | US8110193 Methods for conditioning a subject for hematopoietic cell transplantation |
| 02/07/2012 | US8110192 Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency |
| 02/07/2012 | US8110191 Anti-IL-17 antibodies |
| 02/07/2012 | US8110190 Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the C1 domain of Factor VIII |
| 02/07/2012 | US8110189 Using monoclonal antibody specific to biliary glycoprotein as tool in treatment and prevention of cell proliferative, autoimmune, immunodeficiency and transplant rejection disorders |
| 02/07/2012 | US8110188 Compositions for prevention and treatment of infections caused by coccidia in chickens |
| 02/07/2012 | US8110187 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto |
| 02/07/2012 | CA2509068C Antibody ("11c7") anti nogo a and its pharmaceutical use |
| 02/07/2012 | CA2386463C April receptor (bcma) and uses thereof |
| 02/07/2012 | CA2333147C Cancer treatment methods using antibodies to aminophospholipids |
| 02/07/2012 | CA2328989C Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 02/07/2012 | CA2301964C Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 02/07/2012 | CA2273196C Isolated mammalian monocyte cell genes; related reagents |
| 02/07/2012 | CA2264484C Human plasma hyaluronidase |
| 02/07/2012 | CA2222701C Camp factor of streptococcus uberis |
| 02/02/2012 | WO2012016073A2 Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions |
| 02/02/2012 | WO2012015758A2 Methods of treating pain |
| 02/02/2012 | WO2012015741A2 Combination therapy for treating cancer comprising an igf-1r inhibitor and an akt inhibitor |
| 02/02/2012 | WO2012015696A1 Thymic stromal lymphopoietin (tslp) and ox40 ligand in cancer |